Atlas Trials

Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects

Clinical trial NCT01888393 · COMPLETED

Trial details

NCT number
NCT01888393
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic ImpairmentHealthy
Start date
2013-06-01
Primary completion
2013-11-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.